Search

everythinglearnresearchcommunity

for

Search:↓

Spironolactone is a safe and effective treatment for reducing excessive hair growth in women.

High levels of male hormones and irregular periods best predict how well PCOS patients will respond to metformin treatment.

Excessive body hair in women can be caused by various conditions and treated with medication like Diane® 35 or androgen blockers.

Metformin and liraglutide improved symptoms of HAIR-AN syndrome in a child.

Both estrogens and androgens are important for health in both males and females.

Insulin resistance is a complex condition that can lead to many diseases and has few treatment options.

Obesity leads to physical, metabolic, reproductive issues, higher healthcare costs, and mental health problems.

Older, overweight women with children and a family history of hair loss are more likely to experience female pattern hair loss.

AMH levels can't reliably tell the difference between LOCAH and all types of PCOS in women with excessive hair growth.

Hormone therapies like birth control pills and spironolactone are safe and effective for treating women's adult acne.

Daughters of women with PCOS generally experience normal puberty but may have more body hair and different body fat distribution.

Hormonal treatments can improve acne, but they come with potential side effects and risks.

PCOS may be influenced by factors in the blood, not just the ovaries.

Blood removal and birth control pills both helped with hormone levels in women with PCOS, but birth control was better for regular periods and blood removal had fewer side effects.

Cinnamon can help manage symptoms of polycystic ovary syndrome, improve menstrual cycles and fertility, and positively affect cholesterol and blood sugar levels, but more research is needed to confirm these effects and find the best dosage.

Hormonal therapies are effective for managing hair and skin symptoms in women with PCOS.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Improving insulin sensitivity and weight loss can help manage polycystic ovary syndrome (PCOS).

PCOS is often linked to insulin resistance and obesity, and weight loss can improve symptoms.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

Women with PCOS, especially those overweight, have higher levels of IL-18 in their endometrium, which may affect fertility.

The research suggests that the ZP4 gene is linked to egg development in women with PCOS but requires more study to understand its role in infertility.

Many infertile women with PCOS in Central Vietnam have metabolic or insulin resistance syndrome, with obesity and older age increasing the risk.

Blood tests can detect ovarian Leydig cell tumors when scans don't, and surgery can confirm and treat these tumors.

A 3-month treatment improved PCOS symptoms and reduced certain immune proteins.

Ovarian Hyperthecosis caused hypersexuality in an older woman and was successfully treated with surgery.

Female relatives of PCOS patients have a higher chance of showing PCOS symptoms.

Polycystic ovary syndrome affects about 6-10% of women, with varying symptoms and the need for standardized global definitions.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.